NeuroPace (NPCE) Change in Account Payables (2020 - 2026)
NeuroPace's (NPCE) quarterly Change in Account Payables came in at $2.2 million in Q1 2026, up 127.23% year-on-year from $966000.0 in Q1 2025, and up 192.03% quarter-over-quarter from -$2.4 million in Q4 2025.
NeuroPace (NPCE) Change in Account Payables (2020 - 2026) Analysis & Trends
NeuroPace's Change in Account Payables history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 127.23% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $499000.0, a 27.37% decrease from a year earlier, with the FY2025 full-year figure at -$730000.0, down 208.79% from the prior year.
- Change in Account Payables improved to $2.2 million in Q1 2026 per NPCE's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.2 million in Q1 2026 and bottomed at -$2.4 million in Q4 2025.
- The 5-year median for Change in Account Payables is -$22000.0 (2023), against an average of $177823.5.
- Biggest YoY gain for Change in Account Payables was 592.23% in 2024; the steepest drop was 4090.91% in 2024.
- Year by year, Change in Account Payables stood at $855000.0 in 2022, then climbed by 23.39% to $1.1 million in 2023, then retreated by 26.73% to $773000.0 in 2024, then tumbled by 408.54% to -$2.4 million in 2025, then surged by 192.03% to $2.2 million in 2026.
- Per Business Quant, the three latest NPCE Change in Account Payables figures stand at $2.2 million (Q1 2026), -$2.4 million (Q4 2025), and -$48000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Sep 30, 2025 | -48,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |